| Financial Year |
March 31 2023 |
| Monetary Funds |
540,664,293.80 |
| Held-for-trading Financial Assets |
123,528,660.00 |
| Notes Receivable |
42,588,497.64 |
| Accounts Receivable |
642,560,810.07 |
| Advances to Suppliers |
4,993,847.01 |
| Other Receivables |
8,949,773.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
102,009.47 |
| Dividend Receivable |
-- |
| Inventories |
489,184,362.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
29,305,717.48 |
| Total Current Assets |
1,926,926,215.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
853,398.17 |
| Investment Properties |
-- |
| Fixed Assetes |
1,110,284,402.39 |
| Under-construction Projects |
158,504,068.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,938,235.76 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
24,685,378.90 |
| Deferred Income Tax Assets |
10,735,644.29 |
| Other Non-Current Assets |
1,911,249.35 |
| Sub-Total of Non-Current Assets |
1,430,047,562.53 |
| Total Assets |
3,356,973,777.77 |
| Short-Term Loans |
196,141,833.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
283,289,015.77 |
| Accounts Payable |
703,117,953.39 |
| Accounts Received In Advance |
611,672.15 |
| Employee Compensation Payable |
40,884,052.89 |
| Taxes Payable |
9,057,421.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
38,665,580.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
94,404,167.47 |
| Other Current Liabilities |
22,693,657.26 |
| Sub-Total of Current Liabilities |
1,390,302,231.63 |
| Long-term Loans |
295,755,000.07 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,259,909.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
333,431,727.24 |
| Total Liabilities |
1,723,733,958.87 |
| Paid-In Capital(Or Share Stock) |
101,752,000.00 |
| Capital Surplus |
1,070,124,111.32 |
| Surplus Reserve |
50,885,000.00 |
| LESS:Treasury Stock |
80,697,962.67 |
| Undistributed Profits |
489,046,532.99 |
| Minority Stockholder's Interest |
246,713.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,632,993,105.31 |
| Owner's Equity（Stockholder's Equity） |
1,633,239,818.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,356,973,777.77 |
